How does lanreotide differ from octreotide?

Both are somatostatin analogs with similar receptor binding profiles (preferential SSTR2 and SSTR5 affinity). Key differences: lanreotide Autogel is a pre-filled deep subcutaneous injection enabling self-administration, while octreotide LAR requires IM injection by a healthcare professional. The CLARINET trial provided Level 1 evidence for lanreotide in GEP-NETs; PROMID did so for octreotide in midgut NETs specifically.

Can lanreotide be self-administered?

Yes. Somatuline Autogel is the only somatostatin analog depot formulation designed for deep subcutaneous self-injection. Patients or caregivers can be trained to administer it in the upper outer quadrant of the buttock.

What is the CLARINET trial?

CLARINET (Controlled study of Lanreotide Antiproliferative Response in Neuroendocrine Tumors) was a randomized, double-blind, placebo-controlled Phase III trial (n=204) that demonstrated lanreotide significantly prolonged progression-free survival in nonfunctioning GEP-NETs (HR 0.47, p<0.001). This led to FDA approval for GEP-NETs in 2014.

What is the recommended dose range for Lanreotide?

The research dose range is 60-120 mg every 4 weeks, administered via Deep subcutaneous injection, Once every 4 weeks.

peptide dosing

Lanreotide Dosing & Reconstitution Guide

Q: What is the recommended dose range for Lanreotide?

The research dose range is 60-120 mg every 4 weeks, administered via Deep subcutaneous injection, Once every 4 weeks.

Complete dosing reference for Lanreotide (Endocrine / Somatostatin Analog). Covers reconstitution, dose range, titration schedule, pharmacokinetics, and storage protocols for research use.

Dosing Protocol

Route: Deep subcutaneous injection Frequency: Once every 4 weeks Dose Range: 60-120 mg every 4 weeks Cycle Length: Ongoing as prescribed Timing: Administered in the upper outer quadrant of the buttock

Titration Schedule

Initial: 90 mg deep SC every 4 weeks After 3 months: Adjust to 60 mg or 120 mg based on response (GH, IGF-1, symptoms)

Storage

Lyophilized: Refrigerate at 2-8 °C (36-46 °F) in original packaging Reconstituted: Pre-filled syringe; may be kept at room temperature (up to 25 °C) for up to 4 weeks before use

Injection Sites

Upper outer quadrant of the buttock

Safety & Contraindications

Safety: Common (>10%): diarrhea (26-37%), abdominal pain (14-19%), cholelithiasis (14-20%) Injection site reactions: pain, mass, induration, erythema at injection site (9-22%) Glucose metabolism alterations: hyperglycemia (7-14%) or hypoglycemia (7%)

Contraindications: Known hypersensitivity to lanreotide or related peptides; Caution in patients with diabetes mellitus (monitor blood glucose closely); Caution in patients with cardiac disease (risk of bradycardia)

Peptide Tools

Reconstitution CalculatorCalculate concentration and syringe units for any peptide vial with visual syringe guide.

Dosage & Cycle PlannerPlan a multi-week peptide cycle. Calculate total supply needed and vial counts.

Bacteriostatic Water CalculatorCalculate how many vials of bacteriostatic water you need for your peptide stack.

Cost-Per-Milligram CalculatorCompare vendors side-by-side. Find the best value per milligram and per dose.

Frequently Asked Questions

Related Resources

Browse All Research Peptides

Explore More

Lanreotide Dosing Guide Peptides for Neuroendocrine Tumor Management Peptides for Acromegaly

Research Use Only. The information on this page is compiled from published research literature and is provided for educational purposes only. It does not constitute medical advice. All compounds referenced are intended for in vitro research use by qualified laboratories and institutions.